Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of ABT-450/r/ABT-267 and ABT-333 in Hungary
2014-002962-57Phase 3Completed
- Sponsor
- South-Pest Central Hospital, National Institute of Hematology
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ombitasvir + paritaprevir + ritonavir and dasabuvir in hepatitis C virus infection, sponsored by South-Pest Central Hospital, National Institute of Hematology. Started Sep 2014; status: completed.
02
Drugs
ombitasvir + paritaprevir + ritonavirdasabuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2014-002962-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002962-57.